CRAMP1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.265600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.868650E-01
Normal-vs-Stage2
7.605600E-02
Normal-vs-Stage3
4.285600E-02
Normal-vs-Stage4
5.231600E-01
Stage1-vs-Stage2
9.318000E-01
Stage1-vs-Stage3
5.882000E-02
Stage1-vs-Stage4
7.757200E-01
Stage2-vs-Stage3
7.149800E-02
Stage2-vs-Stage4
6.227400E-01
Stage3-vs-Stage4
2.114800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.382000E-02
Normal-vs-AfricanAmerican
1.719200E-01
Normal-vs-Asian
6.957500E-02
Caucasian-vs-AfricanAmerican
9.874400E-01
Caucasian-vs-Asian
1.708570E-01
AfricanAmerican-vs-Asian
3.996800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.868500E-02
Normal-vs-Female
9.420200E-02
Male-vs-Female
8.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.597800E-01
Normal-vs-Age(41-60Yrs)
1.679790E-01
Normal-vs-Age(61-80Yrs)
6.101900E-02
Normal-vs-Age(81-100Yrs)
5.992100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.941600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.294800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.995400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.020300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.644360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.078800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.043820E-01
Normal-vs-Daily Drinker
3.539700E-02
Normal-vs-Weekly Drinker
1.660210E-01
Normal-vs-Occasional Drinker
2.732600E-01
Normal-vs-Social Drinker
4.984400E-01
Non Drinker-vs-Daily Drinker
3.750200E-01
Non Drinker-vs-Weekly Drinker
9.390200E-01
Non Drinker-vs-Occasional Drinker
3.373600E-01
Non Drinker-vs-Social Drinker
1.244590E-01
Daily Drinker-vs-Weekly Drinker
4.202600E-01
Daily Drinker-vs-Occasional Drinker
8.498400E-02
Daily Drinker-vs-Social Drinker
2.852000E-02
Weekly Drinker-vs-Occasional Drinker
4.748400E-01
Weekly Drinker-vs-Social Drinker
2.356600E-01
Occasional Drinker-vs-Social Drinker
5.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.080000E-02
Normal-vs-Grade 2
1.015530E-02
Normal-vs-Grade 3
2.324200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.675400E-01
Grade 1-vs-Grade 3
1.156570E-01
Grade 1-vs-Grade 4
8.080000E-02
Grade 2-vs-Grade 3
1.459150E-01
Grade 2-vs-Grade 4
1.015530E-02
Grade 3-vs-Grade 4
2.324200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.763500E-02
Normal-vs-NonDiabetic
7.509700E-02
Diabetic-vs-NonDiabetic
3.696800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.454600E-01
Normal-vs-NoPancreatitis
4.719700E-02
Pancreatitis-vs-NoPancreatitis
4.868100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.734770E-01
Normal-vs-N1
5.190000E-02
N0-vs-N1
4.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.620400E-01
Normal-vs-TP53-NonMutant
1.398030E-01
TP53-Mutant-vs-TP53-NonMutant
9.550200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
